GT Medical Technologies Inc. has raised $16 million to expand its commercialization of a targeted radiation therapy for patients with brain tumors.
Led by London-based private equity firm MVM Partners LLP, this latest round follows a $10 million raise in early 2019, bringing its total raise to $29 million. Existing investors San Francisco-based MedTech Venture Partners and Tucson-based BlueStone Venture Partners also participated in the round. READ MORE
—